Patents by Inventor A. Hari Reddi

A. Hari Reddi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8684318
    Abstract: A mechanical lock for railway points comprising an outer tube and a linear arrangement of interlinked components arranged in a core of the outer tube, the interlinked components comprising five coaxially arranged, separately manufactured, elements, including a central tie and two link-rods, the two link rods being respectively interlinked at first ends thereof to opposing ends of the central tie by expandable components.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: April 1, 2014
    Assignee: SPX International Limited
    Inventors: Iqbal Chadda, Hari Reddi
  • Patent number: 8299046
    Abstract: The present invention concerns methods for stimulating the growth and repair of bone and cartilage using synthetic triterpenoids and tricyclic-bis-enones. Examples of suitable triterpenoids include CDDO, CDDO-Me, CDDO-Im, and CDDO-Ethylamide. Examples of tricyclic-bis-enones include TBE-31 and TBE-34.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: October 30, 2012
    Assignees: Trustees of Dartmouth College, Osteoscreen, Inc., The Regents of the Universtiy of California
    Inventors: Michael B. Sporn, Karen T. Liby, Tadashi Honda, Gregory Mundy, Ross Garrett, Hari Reddi, Gordon W. Gribble, Takahiro Niikura
  • Publication number: 20120068022
    Abstract: A mechanical lock for railway points comprising an outer tube and a linear arrangement of interlinked components arranged in a core of the outer tube, the interlinked components comprising five coaxially arranged, separately manufactured, elements, including a central tie and two link-rods, the two link rods being respectively interlinked at first ends thereof to opposing ends of the central tie by expandable components.
    Type: Application
    Filed: September 16, 2011
    Publication date: March 22, 2012
    Inventors: Iqbal CHADDA, Hari Reddi
  • Patent number: 7976861
    Abstract: A method for making an implantable bone material. The method includes providing a bone composition consisting essentially of demineralized human bone, and irradiating the composition at a temperature less than about 0° C.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: July 12, 2011
    Assignee: Biomet Manufacturing Corp.
    Inventor: A. Hari Reddi
  • Publication number: 20100172954
    Abstract: A method for making an implantable bone material. The method includes providing a bone composition consisting essentially of demineralized human bone, and irradiating the composition at a temperature less than about 0° C.
    Type: Application
    Filed: March 15, 2010
    Publication date: July 8, 2010
    Applicant: Biomet Manufacturing Corp.
    Inventor: A. Hari REDDI
  • Patent number: 7678385
    Abstract: A method for making an implantable bone material. The method includes providing a bone composition consisting essentially of demineralized human bone, and irradiating the composition at a temperature less than about 0° C.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: March 16, 2010
    Assignee: Biomet Manufacturing Corp.
    Inventor: A. Hari Reddi
  • Publication number: 20080233195
    Abstract: The present invention concerns methods for stimulating the growth and repair of bone and cartilage using synthetic triterpenoids and tricyclic-bis-enones. Examples of suitable triterpenoids include CDDO, CDDO-Me, CDDO-Im, and CDDO-Ethylamide. Examples of tricyclic-bis-enones include TBE-31 and TBE-34.
    Type: Application
    Filed: November 16, 2007
    Publication date: September 25, 2008
    Applicants: Trustees of Dartmouth College, Regents of the University of California, Osteoscreen, Inc.
    Inventors: Michael B. Spoorn, Karen T. Liby, Tadashi Honda, Gordon Gribble, Gregory Mundy, Ross Garrett, Hari Reddi, Takahiro Niikura
  • Patent number: 7211271
    Abstract: Hydroxyapatite is treated by a combination of nitridation and the application of bone morphogenetic protein or DNA encoding such a protein to improve the tissue compatibility and affinity of the hydroxyapatite, rendering the hydroxyapatite more useful as a material for biomedical implants.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: May 1, 2007
    Assignee: The Regents of the University of California
    Inventors: Subhash H. Risbud, Nancy E. Rashid, A. Hari Reddi
  • Publication number: 20040171109
    Abstract: This invention relates, first, to the discovery of IL-17RL, a receptor for members of the IL-17 cytokine family, particularly IL-17B. IL-17RL is naturally expressed from a 19-exon gene as a 720 amino acid protein and as any of 11 splice variants created from differential splicing of the 19 exons. The invention further relates to the discovery that IL-17B is involved in catabolic degradation of bone and cartilage and that bone and cartilage disorders can be ameliorated by pharmacological manipulation of IL-17B by antibodies or by using IL-17RL as a decoy to reduce IL-17B related catabolic activity. Methods for diagnosing cartilage disorders, and pharmaceutical compositions for slowing or ameliorating bone and cartilage pathologies are also provided.
    Type: Application
    Filed: September 16, 2003
    Publication date: September 2, 2004
    Inventors: Dominik Haudenschild, Larry Rose, Timothy Moseley, A. Hari Reddi
  • Publication number: 20020197297
    Abstract: Hydroxyapatite is treated by a combination of nitridation and the application of bone morphogenetic protein or DNA encoding such a protein to improve the tissue compatibility and affinity of the hydroxyapatite, rendering the hydroxyapatite more useful as a material for biomedical implants.
    Type: Application
    Filed: May 17, 2002
    Publication date: December 26, 2002
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California Corporation
    Inventors: Subhash H. Risbud, Nancy E. Rashid, A. Hari Reddi
  • Publication number: 20020127261
    Abstract: Hydroxyapatite is treated by a combination of nitridation and the application of bone morphogenetic protein to improve the tissue compatibility and affinity of the hydroxyapatite, rendering the hydroxyapatite more useful as a material for biomedical implants.
    Type: Application
    Filed: March 12, 2001
    Publication date: September 12, 2002
    Inventors: Subhash H. Risbud, Nancy E. Rashid, A. Hari Reddi